This week on The Rob & Jai Show, an edition of the OIS Podcast, Dr. Rob Rothman and Dr. Jai Parekh welcome Tomas Navratil, PhD, Chief Development Officer at Glaukos, to discuss the company’s remarkable transformation from MIGS pioneer to a diversified global leader in ophthalmology. Glaukos is advancing a robust pipeline that spans devices, pharmaceuticals, and drug-device combinations—reshaping the future of eye care.

Highlights from the episode include:

• How Glaukos tripled its R&D pipeline over the past decade
• A shift from 100% device focus to 70% pharma or drug-device innovation
• Next-gen iDose TR with double the payload heading into clinical development
• Positive Phase 3 results for Epioxa, a non-surgical therapy for keratoconus

Tune in now to hear how Glaukos is stepping into its next chapter as a true ophthalmic powerhouse.